Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii

References

• Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. 2001;21(2):475–490. doi:10.1148/radiographics.21.2.g01mr09475.
   PubMed Web of Science ®Google Scholar
• Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS. Clinical characteristics of struma ovarii. J Gynecol Oncol. 2008;19(2):135–138. doi:10.3802/jgo.2008.19.2.135.
   PubMedGoogle Scholar
• Willemse PH, Oosterhuis JW, Aalders JG, et al. Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration. Cancer. 1987;60(2):178–182. doi:10.1002/1097-0142(19870715)60:2<178::AID-CNCR2820600210>3.0.CO;2-Q.
   PubMed Web of Science ®Google Scholar
• Dardik RB, Dardik M, Westra W, Montz FJ. Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol. 1999;73(3):447–451. doi:10.1006/gyno.1999.5355.
   PubMed Web of Science ®Google Scholar
• Böcker W. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics. Verh Dtsch Ges Pathol. 2002;86:116–119.
   PubMedGoogle Scholar
• DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol. 2003;89(3):543–548. doi:10.1016/S0090-8258(03)00141-0.
   PubMed Web of Science ®Google Scholar
• Marti JL, Clark VE, Harper H, Chhieng DC, Sosa JA, Roman SA. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid. 2012;22(4):400–406. doi:10.1089/thy.2011.0162.
   PubMed Web of Science ®Google Scholar
• Michels A, Haugen B. Malignant struma ovarii. J Clin Endocrinol Metab. 2010;95(4):1505. doi:10.1210/jc.2009-2376.
   PubMed Web of Science ®Google Scholar
• Billan S, Abdah-Bortnyak R, Cohen H, et al. Metastatic malignant struma ovarii. Isr Med Assoc J. 2011;13(4):247–248.
   PubMed Web of Science ®Google Scholar
• Cabanillas ME, Waguespack SG, Bronstein Y, et al. Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. J Clin Endocrinol Metab. 2010;95(6):2588–2595. doi:10.1210/jc.2009-1923.
   PubMed Web of Science ®Google Scholar
• Cabanillas ME, Hu MI, Durand J-B, et al. Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer. J Thyroid Res. 2011;2011(2011):985780. doi:10.4061/2011/985780.
   PubMedGoogle Scholar
• Cabanillas ME, Habra MA. Lenvatinib: role in thyroid cancer and other solid tumors. Cancer Treat Rev. 2016;42:47–55. doi:10.1016/j.ctrv.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Schlumberger M, Tahara M, Wirth LJ, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015;372(7):621–630. doi:10.1056/NEJMoa1406470.
   PubMed Web of Science ®Google Scholar
• Fleeman N, Houten R, Chaplin M, et al. A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC Cancer. 2019;19(1):1209. doi:10.1186/s12885-019-6369-7.
   PubMed Web of Science ®Google Scholar
• Robboy SJ, Shaco-Levy R, Peng RY, et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol. 2009;28(5):405–422.
   PubMed Web of Science ®Google Scholar
• Kunstmann L, Fénichel P. [Struma ovarii, a rare form of ovarian tumor]. Gynecol Obstet Fertil. 2007;35(1):49–54. doi:10.1016/j.gyobfe.2006.10.030.
   PubMedGoogle Scholar
• Wu M, Hu F, Huang X, Tan Z, Lei C, Duan D. Extensive peritoneal implant metastases of malignant struma ovarii treated by thyroidectomy and 131I therapy: a case report. Medicine (Baltimore). 2018;97(51):e13867. doi:10.1097/MD.0000000000013867.
   PubMed Web of Science ®Google Scholar
• Ukita M, Nakai H, Kotani Y, et al. Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: a case report. Oncol Lett. 2014;8(6):2458–2462. doi:10.3892/ol.2014.2587.
   PubMed Web of Science ®Google Scholar
• McGill JF, Sturgeon C, Angelos P. Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract. 2009;15(2):167–173. doi:10.4158/EP.15.2.167.
   PubMed Web of Science ®Google Scholar
• Yassa L, Sadow P, Marqusee E. Malignant struma ovarii. Nat Clin Pract Endocrinol Metab. 2008;4(8):469–472. doi:10.1038/ncpendmet0887.
   PubMedGoogle Scholar
• Janszen EW, van Doorn HC, Ewing PC, et al. Malignant struma ovarii. Ned Tijdschr Geneeskd. 2008;152(29):1647.
   PubMedGoogle Scholar
• Konez O, Hanelin LG, Jenison EL, Goyal M, Randolph W. Functioning liver metastases on an I-131 whole-body scan: a case of malignant struma ovarii. Clin Nucl Med. 2000;25(6):465–496. doi:10.1097/00003072-200006000-00014.
   PubMed Web of Science ®Google Scholar
• McDougall IR, Krasne D, Hanbery JW, Collins JA. Metastatic malignant struma ovarii presenting as paraparesis from a spinal metastasis. J Nucl Med. 1989;30(3):407–411.
   PubMed Web of Science ®Google Scholar
• Steinman RA, De Castro IO, Shrayyef M, et al. Two cases of malignant struma ovarii with metastasis to pelvic bone. Gynecol Obstet Invest. 2013;75(2):139–144. doi:10.1159/000345863.
   PubMed Web of Science ®Google Scholar
• Checrallah A, Medlej R, Saadé C, Khayat G, Halaby G. Malignant struma ovarii: an unusual presentation. Thyroid. 2001;11(9):889–892. doi:10.1089/105072501316973163.
   PubMed Web of Science ®Google Scholar
• Oudoux A, Leblanc E, Beaujot J, Gauthier-Kolesnikov H. Treatment and follow-up of malignant struma ovarii: regarding two cases. Gynecol Oncol Rep. 2016;17:56–59. doi:10.1016/j.gore.2016.05.014.
   PubMedGoogle Scholar
• Oh JM, Baek SH, Gangadaran P, et al. A novel tyrosine kinase inhibitor can augment radioactive iodine uptake through endogenous sodium/iodide symporter expression in anaplastic thyroid cancer. Thyroid. 2020;30(4):501–518. doi:10.1089/thy.2018.0626.
   PubMed Web of Science ®Google Scholar
• Tirrò E, Martorana F, Romano C, et al. Molecular alterations in thyroid cancer: from bench to clinical practice. Genes (Basel). 2019;10(9):709. doi:10.3390/genes10090709.
   Web of Science ®Google Scholar